Optimizing the treatment approach for ST-segment elevation myocardial infarction in the chest leads

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

BACKGROUND: The treatment of ST-segment elevation myocardial infarction (STEMI) in both chest and other leads chose a single course of mandatory use of percutaneous coronary interventions (PCI) in the first 12 h from the onset of pain. However, a significant proportion of patients, often older age groups, are hospitalized at later terms. Thus, studying the efficiency of primary PCIs in different age groups is of interest, considering the terms of hospitalization and characteristics of thanatogenesis in the absence of reperfusion therapy and with its use.

AIM: This study aimed to optimize the treatment approach of patients with STEMI in the chest leads using the primary percutaneous coronary interventions (PCI) during hospitalization in the first 12 h and subsequent 12–72 h, taking into account the initial risk of death at different ages groups.

MATERIALS AND METHODS: The study included 804 patients with anterior STEMI, who were admitted to the institute from 2008 to 2017. Early PCI was performed in the first 12 h in 311 patients, whereas 272 patients underwent delayed interventions at hospitalization after 12–72 h; additionally, 221 patients, including 124 cases with coronary angiography with late hospitalization, received drug therapy. In early PCI, the ratio of individuals under 65 years, 65–75 years, and over 75 years were 176, 73, and 62, whereas 164, 66, and 42 in delayed PCI, and 126, 47, and 48 without intervention, respectively. In 26 deceased patients after PCI and 39 patients without interventions, the state of the coronary arteries (CA), the area of left ventricular (LV) lesion, and the cause of death were determined.

RESULTS: The absence of reperfusion therapy in the form of PCI in anterior STEMI was established to lead to a progressive decreased myocardial contractile function and formation of an extensive LV aneurysm and high mortality rate, especially in older age groups. Early PCI preserves the contractile function, prevents the LV aneurysm, and significantly reduces mortality. The use of delayed PCI prevents LV dysfunction progression, limits the formation of LV aneurysm, and reduces mortality, which remains high in the absence of PCI. However, delayed PCI, contrary to early used interventions without age restrictions, is mainly performed for isolated lesions, much less often for multiple lesions that are more often present in elderly and senile people. Severe CA disease in these categories of patients increases the risk of intraprocedural complications. Nevertheless, without PCI, a lethal outcome is inevitable in many of them. Thanatogenesis in anterior STEMI is based on the proximal lesion of the anterior interventricular branch in combination with three-vessel CA disease, which causes an extensive infarction area with fatal complications.

CONCLUSIONS: The delayed PCI, by analogy with early used procedures without limitations, optimizes the treatment approach of MI with ST-segment elevation in the chest leads and minimizes mortality in all age groups.

About the authors

Georgy A. Gazaryan

N.V. Sklifosovsky Research Institute for Emergency Medicine

Author for correspondence.
Email: gigls@mail.ru
ORCID iD: 0000-0001-5090-6212

MD, Dr. Sci. (Med.), Professor

Russian Federation, Moscow

Lyalya G. Tyurina

N.V. Sklifosovsky Research Institute for Emergency Medicine

Email: tyurina.lyalya@mail.ru
ORCID iD: 0000-0001-9941-8885
Russian Federation, Moscow

Galina A. Nefedova

N.V. Sklifosovsky Research Institute for Emergency Medicine

Email: nefe_ga@mail.ru

MD, Cand. Sci. (Med.)

Russian Federation, Moscow

Georgy G. Gazaryan

N.V. Sklifosovsky Research Institute for Emergency Medicine

Email: gerdji@inbox.ru
ORCID iD: 0000-0002-8431-7333

MD, Cand. Sci. (Med.)

Russian Federation, Moscow

Igor V. Zakharov

N.V. Sklifosovsky Research Institute for Emergency Medicine

Email: ig-zakharov@yandex.ru
ORCID iD: 0000-0002-3946-6153

MD, Cand. Sci. (Med.)

Russian Federation, Moscow

Vasiliy V. Chestukhin

N.V. Sklifosovsky Research Institute for Emergency Medicine

Email: chestukhin@gmail.com

MD, Dr. Sci. (Med.), Professor

Russian Federation, Moscow

Aleksandr S. Yermolov

N.V. Sklifosovsky Research Institute for Emergency Medicine

Email: gigls@mail.ru

MD, Dr. Sci. (Med.), Professor, Corresponding member of the Russian Academy of Sciences

Russian Federation, Moscow

References

  1. Altarev SS, Barbarash OL, Pomeshkina SA, Kashtalap VV, Zykov MV, Tavlueva EV et al. Predictors of non-fulfillment of reperfusion therapy in patients wit ST-elevation acute coronaru syndrome. Cardiology. 2012;6:4–9. (In Russ).
  2. O’Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;61(4):485–510. doi: 10.1016/j.jacc.2012.11.018
  3. Ibanez B, James S, Agewall S, et al. [2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.]. Kardiol Pol. 2018;76(2):229–313. doi: 10.5603/KP.2018.0041
  4. Saunderson CE, Brogan RA, Simms AD, et al. Acute coronary syndrome management in older adults: guidelines, temporal changes and challenges. Age Ageing. 2014;43(4):450–455. doi: 10.1093/ageing/afu034
  5. Khubutia MSh, Gazaryan GA, Zakharov IV. Reperfusion therapy in the acute period of myocardial infarction. Moscow: GEOTAR-Media. 2010:134–160. (In Russ).
  6. Gazaryan GA, Chestukhin VV, Zakharov IV, Ermolov AS. Efficacy of percutaneous coronary interventions in acute period of anterior myocardial infarction with consideration of differently organized endovascular radiology service. Medical alphabet. 2020;36(4):5–10. (In Russ). doi: 10.33667/2078-5631-2020-36-5-10
  7. Morrow DA, Antman EM, Charlesworth A, et al. TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation. 2000;102(17):2031–2037. doi: 10.1161/01.cir.102.17.2031
  8. Nefyodova GA, Galankina IE. Features of thanatogenesis and the extent of myocardial infarction depending on the prevalence of athe rosclerotic stenosis of the coronary arteries. Archive of Patho logy. 2004;(4):17–20. (Russ).
  9. Ahmed AH, ElHadidy A, Helmy M, et al. Myocardial perfusion grade by coronary angiography can predict final infarct size and left ventricular function in patients with ST-elevation myocardial infarction treated with a pharmaco-invasive strategy. Open Access Maced J Med Sci. 2021;9(B):184–190. doi: 10.3889/oamjms.2021.5815.
  10. Henriques JP, Zijlstra F, van ‘t Hof AW, et al. Angiographic assessment of reperfusion in acute myocardial infarction by myocardial blush grade. Circulation. 2003;107(16):2115–2119. doi: 10.1161/01.CIR.0000065221.06430.ED
  11. Hamada S, Nishiue T, Nakamura S, et al. TIMI frame count immediately after primary coronary angioplasty as a predictor of functional recovery in patients with TIMI 3 reperfused acute myocardial infarction. Journal of the American College of Cardiology. 2001;38(3):666–671. doi: 10.1016/s0735-1097(01)01424-3
  12. Vahdatpour C, Collins D, Goldberg S. Cardiogenic Shock. J Am Heart Assoc. 2019;8(8):e011991. doi: 10.1161/JAHA.119.011991

Copyright (c) 2021 Gazaryan G.A., Tyurina L.G., Nefedova G.A., Gazaryan G.G., Zakharov I.V., Chestukhin V.V., Yermolov A.S.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies